Six hundred employees were reportedly hired by Pfizer three months after the release of the [COVID-19] vaccine.
The mass hiring of the pharma company was made after the “large increase” of reports of side effects linked to the vaccine.
According to the document, Pfizer has “taken multiple actions to help alleviate the large increase of adverse event reports,” the document also added, “This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.”
Pfizer said, “More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The said document titled “cumulative analysis of post-authorization adverse event reports” was approved by the FDA on April 30, 2021.
Dr. Aaron Kheriarty highlighted the information in an April 4 tweet which included a screenshot of the relevant section of the document.
Kheriarty is a member of the Public Health and Medical Professionals for Transparency (PHMPT) organization, the group of over 30 physicians and researchers that filed the FOIA lawsuit against the U.S. Food and Drug Administration (FDA) last year to demand the release of the documents it reviewed prior to greenlighting the Pfizer-BioNTech COVID shots.
Kheriarty wrote:
“Finally got the unredacted version of this FoIA’d document. Three months after the release of the [COVID-19] vaccine Pfizer had to hire 600 additional full-time employees, with a plan to hire 1800 total, just to process the flood of adverse events reported.”
Finally got the unredacted version of this FoIA’d document. Three months after the release of the vaccine Pfizer had to hire 600 additional full-time employees, with a plan to hire 1800 total, just to process the flood of adverse events reported. pic.twitter.com/5emJ0s9djl
— Aaron Kheriaty, MD (@akheriaty) April 4, 2022
The Defender reported the unredacted document released on April 1:
“Pfizer has also taken a multiple actions [sic] to help alleviate the large increase of adverse event reports. This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.
“To date, Pfizer has onboarded approximately 600 additional full-time employees (FTEs).
“More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The unredacted version also revealed the number of Pfizer-BioNTech vaccine doses shipped worldwide between December 2020 and February 2021:
“It is estimated that approximately 126,212,580 doses of BNT162b2 [the Pfizer EUA vaccine] were shipped worldwide from the receipt of the first temporary authorisation for emergency supply on 01 December 2020 through 28 February 2021.”
Pfizer was asked via email how many workers it has onboarded to deal with adverse events, however; they have not responded to this question.
Meanwhile, the other two vaccine companies Moderna and Johnson & Johnson did not respond when asked if they have seen an increase in adverse events and if they have hired more employees to deal with reports.
Sources: The Epoch Times, The True Defender
